openPR Logo
Press release

Leishmaniasis Treatment Market Expected to Raise at CAGR of 8.8% by 2019-2026 | Top Companies - Sanofi S.A., Sequus Pharmaceuticals Inc., Paladin Labs Inc., Gland Pharma Limited, etc.

02-24-2020 11:44 AM CET | Health & Medicine

Press release from: Reports And Data

Leishmaniasis Treatment Market Size - USD 104.8 Billion in 2018, Market Growth - CAGR of 8.8%,

Leishmaniasis Treatment Market Size - USD 104.8 Billion in 2018, Market Growth - CAGR of 8.8%,

According to the current analysis of Reports and Data, the global Leishmaniasis Treatment market was valued at USD 104.8 million in 2018 and is expected to reach USD 206.5 million by the year 2026, at a CAGR of 8.8%. A disease outbreak takes place when a disease escalates by a higher number than expected in a region or during a season. An outbreak may occur in one community or even extend to several countries altogether.

Avail the inside scoop of the Sample report @ https://www.reportsanddata.com/sample-enquiry-form/2153

Companies considered and profiled in this market study

Sanofi S.A., Sequus Pharmaceuticals Inc., Paladin Labs Inc., Enzon Pharmaceuticals Inc., Gland Pharma Limited, Gilead Life sciences and Lifecare Innovations Private Limited.

There was a time when people in all countries and on all continents remain chronically vulnerable to infectious diseases, known and unknown. Leishmaniasis was the neglected tropical disease (NTD) that has threatened the people worldwide as per the WHO. Leishmaniasis is a major complex of protozoal vector-borne diseases that affects both humans and animals. The disease is caused by different species of Leishmania, and it is manifested by three major clinical forms named as cutaneous, mucosal and visceral leishmaniasis. Leishmaniasis is transmitted by the bite of infected female sand flies. In each of these forms, infection ranges from causing no symptoms (asymptomatic infection) to severe, even life-threatening complications.

According to the National Organization of Rare Disorders, only a small percentage of people infected by Leishmania parasites will go on to actually develop the disease. There is uneven global distribution of the disease often because of the various distribution pattern of the parasite, the vector and the reservoir host species. Efforts to increase visceral leishmaniasis surveillance, vector control, diagnosis, and treatment are making important progress all across the world. In 2012, WHO launched an action plan for reducing the impact of Neglected Tropical Diseases (NTDs), including visceral leishmaniasis. Leishmaniasis is seldom encountered in the United States.

Further key findings from the report suggest
1. North America is expected to account for the largest market share of 2% of the Leishmaniasis treatment market, owing it to the prevalence of unhealthy lifestyle, high number of target diseases, rise in number of product approval by FDA, ongoing clinical trials, and favorable government regulations scenario contributing to the development of healthcare and therapeutics

2. Europe is the second largest regional segment with the market share of 28.4% in 2018, due to the increased awareness of availability of different therapies and drugs for the treatment and rising awareness about innovations and advancements in Leishmaniasis treatment in pharmaceutical molecules, coupled with increasing incidences of target diseases across the world

Ask Here to Get customization & Check for irresistible discount rates on this report @ https://www.reportsanddata.com/discount-enquiry-form/2153

For the purpose of this report, Reports and Data has segmented the Leishmaniasis Treatment market on the basis of Disease type, pathological tests, therapy type, end use and region:

Disease Type (Revenue, USD Million; 2016-2026)
Cutaneous Leishmaniasis
Mucosal Leishmaniasis
Visceral Leishmaniasis

Pathological tests (Revenue, USD Million; 2016-2026)
By Serological Tests
Parasitological Evaluation
DNA- Based Methods
Immunological Methods
Others

Therapy type (Revenue, USD Million; 2016-2026)
By Drug Therapy
Pentavalent Antimonials
Antifungal
Antibiotics
By Non-Drug Therapy

End Use Revenue, USD Million; 2016-2026)
Hospitals
Clinics
Diagnostic Laboratory
Others

Regional Outlook (Revenue, USD Million; 2016-2026)
North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies @ https://www.reportsanddata.com/report-detail/leishmaniasis-treatment-market

Key selling points of this research study
1. The study gives an in-depth evaluation of the evolving competitive scenario that gives the reader/client a competitive edge.

2. It offers a holistic view of all critical aspects boosting or limiting the growth of the sector

3. The market intelligence report derives an eight-year forecast, including historical, contemporary, and potential market prospects, projecting the estimated progress of the market.

4. It aids informed decision-making by offering an exhaustive database of the pivotal market segments and sub-segments

Contact Us:

John Watson
Head of Business Development
Reports And Data
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leishmaniasis Treatment Market Expected to Raise at CAGR of 8.8% by 2019-2026 | Top Companies - Sanofi S.A., Sequus Pharmaceuticals Inc., Paladin Labs Inc., Gland Pharma Limited, etc. here

News-ID: 1942452 • Views: 378

More Releases from Reports And Data

Deep Brain Stimulation Devices Market Size, Company Revenue Share, Key Drivers & …
The global deep brain stimulation devices market size is expected to reach USD 2.48 Billion in 2028 and register a CAGR of 10.2% over the forecast period, according to the latest report by Reports and Data. Rising incidence rate of neurological disorders, rapidly aging population, and increasing advancements in imaging technologies are some key factors expected to drive market revenue growth over the forecast period. Recent advancements in neuroimaging has significantly improved Deep
Electric Intercity Bus Market Recent Technological Advancements to Propel Growth …
The Global Electric Intercity Bus Market Research report published by Reports and Data encompasses vial information and insights of the Electric Intercity Bus market during the forecast period. It covers data on leading segments such as types, applications, regions, technology, and major players involved in the industry. The report offers details about the major technological breakthroughs, product developments, expansion, key strategic ventures, and other vital advancements in the. The report also covers
Textile Films Market Trends, Revenue, Major Players, Share Analysis & Forecast T …
The global textile films market is forecast to reach USD 8,518.1 Million by 2028, according to a new report by Reports and Data. The market growth is attributed to a combination of various market factors. One of the mentionable factors in this regards are changing preference among end-users and raising awareness & demand for eco-friendly products. This changing preference among end-users have increased the demand for Polyurethane (PU) based films
Styrene Market Revenue, Product Launches, Regional Share Analysis & Forecast Til …
A comprehensive report on the Global Styrene Market has been published by Reports and Data that offers insightful data about market dynamics, drivers, restraints, current and emerging trends, market size, market share, and revenue growth of the market. The report provides a brief overview of the industry and gives an estimation of growth and revenue for the forecast period of 2021-2028. The global Styrene market is expected to be valued

All 5 Releases